| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.88 | 0.09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |